Massive myelomatous ascites responsive to VAD chemotherapy and autologous stem cell transplantation

Bone Marrow Transplant. 1999 Aug;24(3):343-4. doi: 10.1038/sj.bmt.1701892.

Abstract

Plasmacytic ascites is an infrequent complication of multiple myeloma. To date, only few cases have been reported with a very rapidly fatal course unresponsive to therapy. We describe a patient with plasmacytic ascites and quiescent multiple myeloma of 8 years of duration. Disease progression became apparent due to myelomatous ascites, unexplained fever, pancytopenia and bone marrow infiltration. This case showed a complete and long-lasting response after VAD chemotherapy followed by autologous PBSC transplantation. Ascites in association with MM may respond for lengthy periods to high-dose chemotherapy and ASCT.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Ascites / therapy*
  • Dexamethasone / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Middle Aged
  • Multiple Myeloma / therapy*
  • Transplantation, Autologous
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Dexamethasone
  • Doxorubicin

Supplementary concepts

  • VAD protocol